Pfizer JKI 5 Pill - white round, 8mm
Generic Name: tofacitinib
Pill with imprint Pfizer JKI 5 is White, Round and has been identified as Xeljanz 5 mg. It is supplied by Pfizer, Inc.
Xeljanz is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Polyarticular Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Ulcerative Colitis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer JKI 5
Xeljanz
- Generic Name
- tofacitinib
- Imprint
- Pfizer JKI 5
- Strength
- 5 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer, Inc.
- National Drug Code (NDC)
- 00069-1001
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
croscarmellose sodium,
magnesium stearate,
titanium dioxide,
triacetin,
polyethylene glycol 3350,
hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
More about Xeljanz (tofacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (145)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.